The Prevalence of Coagulation Factor Deficiency Among Pediatric Populations in Medina City, Saudi Arabia

Clinical Laboratory
|April 14, 2026
PubMed

Insights

Coagulation factor deficiencies are common in children in Medina, Saudi Arabia. Early diagnosis and monitoring of platelet counts and coagulation profiles are crucial for managing inherited bleeding disorders.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Genetics

Background:

  • Coagulation factor deficiencies are inherited bleeding disorders impacting blood clotting.
  • These conditions result from insufficient or dysfunctional coagulation factors.
  • Prevalence and impact on pediatric patients in Medina, Saudi Arabia, were investigated.

Purpose of the Study:

  • To determine the prevalence of coagulation factor deficiencies in pediatric patients.
  • To assess the impact of these deficiencies on platelet counts and coagulation parameters.
  • To provide insights into bleeding disorder management in the region.

Main Methods:

  • Retrospective analysis of 221 pediatric patients with coagulation factor deficiencies.
  • Inclusion of a control group of 50 healthy children for comparison.
  • Extraction of clinical and laboratory data including platelet count, PT, INR, APTT, and factor levels.

Main Results:

  • Factor VIII (hemophilia A) and Factor IX (hemophilia B) were the most common deficiencies.
  • Significantly prolonged prothrombin time, INR, and APTT observed in deficient patients (p < 0.0001).
  • Prevalence was similar between males (50.22%) and females (49.78%).

Conclusions:

  • High prevalence necessitates early diagnosis, genetic counseling, and specialized care.
  • Comprehensive management requires close monitoring of coagulation profiles and platelet counts.
  • Findings highlight the importance of monitoring in children with bleeding symptoms.
Abstract

Related Concept Videos

Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...